Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.


Journal

European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857

Informations de publication

Date de publication:
03 Aug 2021
Historique:
received: 21 05 2021
accepted: 27 07 2021
entrez: 4 8 2021
pubmed: 5 8 2021
medline: 10 8 2021
Statut: epublish

Résumé

The COVID-19 pandemic has markedly impacted on cultural, political, and economic structures all over the world. Several aspects of its pathogenesis and related clinical consequences have not yet been elucidated. Infection rates, as well morbidity and mortality differed within countries. It is intriguing for scientists to understand how patient genetics may influence the outcome of the condition, to clarify which aspects could be related the clinical variability of SARS-CoV-2 disease. We reviewed the studies exploring the role of human leukocyte antigens (HLA) genotypes on individual responses to SARS-CoV-2 infection and/or progression, discussing also the contribution of the immunological patterns MHC-related. In March 2021, the main online databases were accessed. All the articles that investigated the possible association between the HLA genotypes and related polymorphisms with susceptibility, severity and progression of COVID-19 were considered. Although both genetic and environmental factors are certainly expected to influence the susceptibility to or protection of individuals, the HLA and related polymorphisms can influence susceptibility, progression and severity of SARS-CoV-2 infection. The crucial role played by HLA molecules in the immune response, especially through pathogen-derived peptide presentation, and the huge molecular variability of HLA alleles in the human populations could be responsible for the different rates of infection and the different patients following COVID-19 infection.

Identifiants

pubmed: 34344463
doi: 10.1186/s40001-021-00563-1
pii: 10.1186/s40001-021-00563-1
pmc: PMC8329616
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

84

Informations de copyright

© 2021. The Author(s).

Références

Front Immunol. 2019 May 28;10:1179
pubmed: 31231370
Front Immunol. 2019 Jun 19;10:1415
pubmed: 31316503
Curr Opin Rheumatol. 2013 Jul;25(4):426-33
pubmed: 23656712
Travel Med Infect Dis. 2020 Jul - Aug;36:101607
pubmed: 32112857
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430
pubmed: 32145190
J Infect Dis. 2015 Sep 15;212(6):939-47
pubmed: 25740956
Ann Thorac Med. 2016 Jul-Sep;11(3):211-3
pubmed: 27512511
J Hum Genet. 2020 Dec;65(12):1075-1082
pubmed: 32699345
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Nature. 1991 Nov 14;354(6349):95
pubmed: 1944599
J Virol. 2020 Jun 16;94(13):
pubmed: 32303592
J Hum Genet. 2020 Jul;65(7):569-575
pubmed: 32372051
N Engl J Med. 2020 Oct 15;383(16):1522-1534
pubmed: 32558485
Bioinformatics. 2021 Jan 29;36(21):5271-5273
pubmed: 32853340
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
HLA. 2020 Nov;96(5):610-614
pubmed: 32827207
Immun Inflamm Dis. 2020 Dec;8(4):684-694
pubmed: 33047883
Infez Med. 2020 Mar 1;28(1):3-5
pubmed: 32009128
Br Med Bull. 2005 Feb 08;71:93-113
pubmed: 15701924
Nat Med. 2020 Apr;26(4):453-455
pubmed: 32284614
Tissue Antigens. 2002 Apr;59(4):338-40
pubmed: 12135438
J Microbiol Immunol Infect. 2020 Jun;53(3):425-435
pubmed: 32414646
J Med Virol. 2020 May;92(5):522-528
pubmed: 32027036
Front Immunol. 2016 Jul 25;7:281
pubmed: 27504110
Malays J Pathol. 2020 Apr;42(1):3-11
pubmed: 32342926
J Immunol Res. 2018 Feb 25;2018:3174868
pubmed: 29682588
J Transl Med. 2020 May 5;18(1):185
pubmed: 32370758
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Allergy Clin Immunol. 2020 Jul;146(1):110-118
pubmed: 32294485
Int J Mol Sci. 2020 Jul 23;21(15):
pubmed: 32717807
J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):356-361
pubmed: 29528943
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12964-12973
pubmed: 31138701
Int J Public Health. 2020 Jun;65(5):533-546
pubmed: 32451563
J Pharm Anal. 2020 Apr;10(2):102-108
pubmed: 32282863
Saudi Med J. 2015 Apr;36(4):484-6
pubmed: 25828287
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Microbes Infect. 2020 Mar;22(2):72-73
pubmed: 32092539
Cell Discov. 2020 Nov 10;6(1):83
pubmed: 33298875
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Respirology. 2018 Feb;23(2):130-137
pubmed: 29052924
Tissue Antigens. 1989 Jan;33(1):21-9
pubmed: 2711369
J Chin Med Assoc. 2020 Mar;83(3):217-220
pubmed: 32134861
Science. 2020 May 8;368(6491):630-633
pubmed: 32245784
Cell Rep. 2020 Jun 2;31(9):107725
pubmed: 32426212
J Transl Med. 2020 Sep 15;18(1):352
pubmed: 32933522
HLA. 2020 Sep;96(3):277-298
pubmed: 32475052
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
J Clin Microbiol. 2006 Feb;44(2):359-65
pubmed: 16455884
Front Immunol. 2020 Dec 04;11:605688
pubmed: 33343579
Viruses. 2020 Feb 22;12(2):
pubmed: 32098422
Hum Immunol. 2009 Jul;70(7):527-31
pubmed: 19445991
Lancet. 2001 Jun 23;357(9273):2037-41
pubmed: 11438157
Pathogens. 2020 Mar 04;9(3):
pubmed: 32143502
Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S207-14
pubmed: 15577575
J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):121-31
pubmed: 17106278
SN Compr Clin Med. 2020;2(10):1798-1801
pubmed: 32904860
ChemRxiv. 2020 Apr 21;:
pubmed: 32511291
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Methods Mol Biol. 2007;409:293-9
pubmed: 18450009
Crit Rev Immunol. 2017;37(2-6):75-120
pubmed: 29773018
World J Clin Pediatr. 2016 Nov 8;5(4):391-396
pubmed: 27872828
Immunity. 2020 Jul 14;53(1):19-25
pubmed: 32610079
Gastroenterology. 2000 Feb;118(2):274-8
pubmed: 10648455
PLoS Pathog. 2012;8(7):e1002805
pubmed: 22807681
Emerg Microbes Infect. 2012 Sep;1(9):e23
pubmed: 26038429
J Infect Dis. 2004 Aug 1;190(3):515-8
pubmed: 15243926
Nucleic Acids Res. 2015 Jan;43(Database issue):D784-8
pubmed: 25414323
Nat Med. 2020 Apr;26(4):465
pubmed: 32273606
mBio. 2020 May 29;11(3):
pubmed: 32471829
Ann N Y Acad Sci. 2007 Apr;1102:26-38
pubmed: 17470909
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Genome Med. 2020 Oct 27;12(1):93
pubmed: 33109261
Viral Immunol. 2011 Oct;24(5):421-6
pubmed: 21958371
Geroscience. 2020 Aug;42(4):1015-1019
pubmed: 32583231
Nat Rev Immunol. 2018 May;18(5):325-339
pubmed: 29292391
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792
pubmed: 32687793
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Nat Med. 2020 Jul;26(7):1149-1150
pubmed: 32661399
Nat Immunol. 2002 Nov;3(11):1019-25
pubmed: 12407410
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Autoimmun. 2020 May;109:102434
pubmed: 32143990
Med Intensiva (Engl Ed). 2021 Mar;45(2):96-103
pubmed: 32988645
HLA. 2020 Aug;96(2):194-196
pubmed: 32424945
Cells. 2019 Oct 17;8(10):
pubmed: 31627481
J Formos Med Assoc. 2020 Mar;119(3):670-673
pubmed: 32139299
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Clin Immunol. 2006 Jun;119(3):346-50
pubmed: 16542878
Immunotherapy. 2019 Dec;11(18):1523-1526
pubmed: 31865873
HIV Med. 2017 Sep;18(8):587-594
pubmed: 28218480
Front Immunol. 2019 Mar 04;10:349
pubmed: 30886616
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Vet Immunol Immunopathol. 2005 Aug 15;107(1-2):1-15
pubmed: 15978672
HLA. 2021 Feb;97(2):127-132
pubmed: 33179437
Viruses. 2020 Nov 20;12(11):
pubmed: 33233780
BMC Med. 2020 Jul 15;18(1):216
pubmed: 32664879
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9
pubmed: 32105090
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Inflamm Bowel Dis. 2016 Apr;22(4):796-806
pubmed: 26891255
J Med Virol. 2020 Apr;92(4):424-432
pubmed: 31981224
Hong Kong Med J. 2010;16(5 Suppl 4):29-33
pubmed: 20864745
Sci Rep. 2014 Aug 07;4:5981
pubmed: 25099678
Euro Surveill. 2020 Jul;25(28):
pubmed: 32700671
Front Immunol. 2021 Jan 08;11:601886
pubmed: 33488597
bioRxiv. 2021 Mar 17;:
pubmed: 33398276
BMC Med Genet. 2003 Sep 12;4:9
pubmed: 12969506
medRxiv. 2020 Nov 04;:
pubmed: 33173878
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Filippo Migliorini (F)

Department of Orthopaedic and Trauma Surgery, RWTH University Hospital, Pauwelsstraße 30, 52074, Aachen, Germany. migliorini.md@gmail.com.

Ernesto Torsiello (E)

Department of Medicine, Surgery and Dentistry, University of Salerno, Via S. Allende, 84081, Baronissi, SA, Italy.

Filippo Spiezia (F)

Ospedale San Carlo Potenza, Via Potito Petrone, 85100, Potenza, Italy.

Francesco Oliva (F)

Department of Medicine, Surgery and Dentistry, University of Salerno, Via S. Allende, 84081, Baronissi, SA, Italy.

Markus Tingart (M)

Department of Orthopaedic and Trauma Surgery, RWTH University Hospital, Pauwelsstraße 30, 52074, Aachen, Germany.

Nicola Maffulli (N)

Department of Medicine, Surgery and Dentistry, University of Salerno, Via S. Allende, 84081, Baronissi, SA, Italy.
Faculty of Medicine, School of Pharmacy and Bioengineering, Keele University, Thornburrow Drive, Stoke on Trent, England.
Barts and the London School of Medicine and Dentistry, Centre for Sports and Exercise Medicine, Mile End Hospital, Queen Mary University of London, 275 Bancroft Road, London, E1 4DG, England.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH